1. Home
  2. CASI vs CLIR Comparison

CASI vs CLIR Comparison

Compare CASI & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • CLIR
  • Stock Information
  • Founded
  • CASI 1991
  • CLIR 2008
  • Country
  • CASI China
  • CLIR United States
  • Employees
  • CASI N/A
  • CLIR N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • CLIR Industrial Machinery/Components
  • Sector
  • CASI Health Care
  • CLIR Industrials
  • Exchange
  • CASI Nasdaq
  • CLIR Nasdaq
  • Market Cap
  • CASI 35.8M
  • CLIR 30.7M
  • IPO Year
  • CASI 1996
  • CLIR 2012
  • Fundamental
  • Price
  • CASI $2.01
  • CLIR $0.50
  • Analyst Decision
  • CASI Strong Buy
  • CLIR Strong Buy
  • Analyst Count
  • CASI 1
  • CLIR 1
  • Target Price
  • CASI $4.00
  • CLIR $2.00
  • AVG Volume (30 Days)
  • CASI 76.1K
  • CLIR 80.2K
  • Earning Date
  • CASI 11-13-2025
  • CLIR 11-13-2025
  • Dividend Yield
  • CASI N/A
  • CLIR N/A
  • EPS Growth
  • CASI N/A
  • CLIR N/A
  • EPS
  • CASI N/A
  • CLIR N/A
  • Revenue
  • CASI $31,564,000.00
  • CLIR $2,983,000.00
  • Revenue This Year
  • CASI N/A
  • CLIR $13.13
  • Revenue Next Year
  • CASI N/A
  • CLIR $143.88
  • P/E Ratio
  • CASI N/A
  • CLIR N/A
  • Revenue Growth
  • CASI 36.64
  • CLIR 19.03
  • 52 Week Low
  • CASI $1.09
  • CLIR $0.46
  • 52 Week High
  • CASI $7.50
  • CLIR $1.72
  • Technical
  • Relative Strength Index (RSI)
  • CASI 50.04
  • CLIR 32.84
  • Support Level
  • CASI N/A
  • CLIR $0.52
  • Resistance Level
  • CASI $2.49
  • CLIR $0.57
  • Average True Range (ATR)
  • CASI 0.17
  • CLIR 0.03
  • MACD
  • CASI -0.14
  • CLIR -0.01
  • Stochastic Oscillator
  • CASI 80.40
  • CLIR 28.95

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About CLIR ClearSign Technologies Corporation (DE)

ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.

Share on Social Networks: